Advancing Vaginal Health Products: Addressing BV and STI/HIV Prevention Through Next-Generation MPTs
February 2026
Click for full info +This session of IMPT’s Let’s Talk MPTs webinar series explores how next-generation multipurpose prevention technologies (MPTs) can integrate BV management with STI/HIV prevention in single, user-controlled products. Bacterial vaginosis (BV) significantly increases vulnerability to HIV and other sexually transmitted infections (STIs), yet remains under-addressed in prevention strategies.
Presenters:
Ishita Shah, PhD (Matrubials, Inc.) discussed antimicrobial peptides for treatment/prevention of BV and other STIs; and
Laurel Lagenaur, PhD (Osel Inc.) presented on live bacterial therapeutics for BV and HIV/STI prevention; and
Jen Balkus, PhD, MPH (University of Washington | Public Health Seattle & King County) framed the public health link between BV and infection risk.
Moderator:
Bethany Young Holt PhD, MPH Executive Director of the Initiative for Multipurpose Prevention Technologies (IMPT) | CAMI Health.
View webinar recording
Download presentations:
Dr. Jen Balkus – Bacterial vaginosis and HIV/STIs: The role of MPTs?
Dr. Ishita Shah – Antimicrobial Peptides for Treatment/Prevention of Bacterial Vaginosis and other STIs
Dr Laurel Lagenaur – Live Biotherapeutics to Modify the Vaginal Microbiota for Women’s Health
Full Info:
Resource Type:
Authors: Jen Balkus PhD, MPH (University of Washington | Public Health Seattle & King County), Ishita Shah PhD (Matrubials Inc.), Laurel Lagenaur PhD (Osel Inc.) and the IMPT.
URL of resource: